Overview
Status
Active
Registry date
2021-12-10
Share capital
6,050.00 PLN
Registered address
ul. Piotrkowska 46/8u, 90-265 Łódź, Poland
Email
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 2 days early.
- 202514/07/2026
- 202414/07/2025
- 202313/07/2024
- 202213/07/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 50.23kMedianUSD 818.63kAverageUSD 7.98m
Net profit
This companyUSD 14.34kMedianUSD 20.51kAverageUSD 554.06k
Operating costs
This companyUSD 35.89kMedianUSD 642.78kAverageUSD 7.07m
Assets
This companyUSD 214.14kMedianUSD 826.85kAverageUSD 6.62m
Industry
Authorized Representatives
Katarzyna - Cioch – President of the Management Board
Manner of representation
If the management board is a multi-member management board, the President of the Management Board or a member of the management board is authorized to submit declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 109 | $1,472.18 | 90.0826% | |
Others | 12 | $162.07 | 9.9174% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-01-01.
37 1020 3408 0000 4702 0514 1827
51 1020 3408 0000 4702 0503 6233
56 1020 3408 0000 4502 0503 6241
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 19, 2020 | Aid for SME access to finance — aid for start-ups | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Stethomesp. z o.o. | $267,112.27 | stethome.com | ||
| ChitomedP.S.A. | $206,587.41 | chitomed.com | ||
| Orto Novasp. z o.o. | $158,631.83 | zarychta.com.pl | ||
| ClebreS.A. | $87,678.59 | clebre.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-12-17 | Address change (Ul. Piotrkowska 46/9u, 90-265, Łódź → Ul. Piotrkowska 46/8u, 90-265, Łódź) | |
| 2024-09-04 | Address change (Ul. Tomasza Judyma 15/50, 91-134, Łódź → Ul. Piotrkowska 46/9u, 90-265, Łódź) | |
| 2023-09-04 | Share capital increase (5,000.00 PLN → 6,050.00 PLN) | |
| 2021-12-10 | Entered in the register |
FAQ
The main business activity of Stentpoint P focuses on manufacture of other medical instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on December 10, 2021.
The headquarters is located at: ul. Piotrkowska 46, 90-265 Łódź.
The management board consists of: Katarzyna Potargowicz - Cioch (President of the Management Board).
The share capital of the company is PLN 6,050 (approx. $1,634).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company's revenue reached USD 50,226.
Yes, in 2025 the company was profitable, achieving a net profit of USD 14,339.
The largest operating cost category falls under other operating costs. This category amounted to USD 35,887 in 2025, representing 100% of all operating expenses.
Last updated: 2026-10-06